Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a drug named Fluvastatin is beneficial and
safe in reducing the risk of cardiovascular disease and blood clots in patients with
antiphospholipid antibodies or Antiphospholipid Syndrome (APS).